Trial Profile
Safety and efficacy study using ABT-335 [Choline fenofibrate] (investigational drug) in combination with atorvastatin, to study the effects on thickening of the blood vessel wall in patients with abnormal lipid (fat) levels in the blood (FIRST).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2018
Price :
$35
*
At a glance
- Drugs Choline fenofibrate (Primary) ; Atorvastatin
- Indications Dyslipidaemias
- Focus Pharmacodynamics; Registrational
- Acronyms FIRST
- Sponsors Abbott Laboratories; AbbVie
- 10 Mar 2013 Primary endpoint 'Intima-media-thickness' has not been met.
- 10 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.